NeolibTM 

NeoLibTM  is a customized vaccine library built using big own data including tumor bank (300 patients), validated immunogenicity of 650 HLA-peptide

combinations.

 NeoLibTM will enable a coverage of at least 20% of cancer patient. Such coverage enable vaccine pre-produced in mass and reduce the treatment cost to US$15K per patient

SCIENTIFIC PROBES:
1 publication

1 patent filed to USPTO